MTOR and neoplasm: Although some studies have shown that Osthole, an active ingredient in MQSD, can attenuate the phosphorylation levels of AMPK, Akt and mTOR in HCT116 and SW480 cells, inducing cellular ferroptosis and exerting anti‐tumour effects [46], these findings are specific to tumour cells.